e-learning
resources
Munich 2006
Monday 04.09.2006
Cystic fibrosis lung disease: molecules images and drugs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis
L. J. van der Giessen, J. C. de Jongste, R. Gosselink, W. C. J. Hop, H. A. W. M. Tiddens (Rotterdam, Netherlands; Leuven, Belgium)
Source:
Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Session:
Cystic fibrosis lung disease: molecules images and drugs
Session type:
Oral Presentation
Number:
1976
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. J. van der Giessen, J. C. de Jongste, R. Gosselink, W. C. J. Hop, H. A. W. M. Tiddens (Rotterdam, Netherlands; Leuven, Belgium). RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis. Eur Respir J 2006; 28: Suppl. 50, 1976
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Related content which might interest you:
Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect
Source: Eur Respir J 2004; 24: 95-100
Year: 2004
Long-term clearance from small airways in patients with cystic fibrosis
Source: Eur Respir J 2005; 25: 317-323
Year: 2005
Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014
Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis
Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017
Year: 2018
Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia
Source: Eur Respir J 2016; 47: 829-836
Year: 2016
Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis
Source: Eur Respir J 2002; 20: 122-126
Year: 2002
Airway clearance techniques in cystic fibrosis
Source: Eur Respir J 2006; 27: 1082-1083
Year: 2006
A short-term comparison of two methods of sputum expectoration in cystic fibrosis
Source: Eur Respir J 2004; 23: 435-439
Year: 2004
Measurement of airways obstruction among preschoolers with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
Regular exercise improves airway inflammation in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Knowledge and adherence of airway clearance techniques in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Respiratory physiotherapy: outcomes in disease and health
Year: 2015
Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010
Pharmacological airway clearance strategies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 239-247
Year: 2011
The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020
The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects
Year: 2007
Treatment of atelectasis and severe mucus plugging in cystic fibrosis.
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Pulmonary function of infants with cystic fibrosis, with and without respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 529s
Year: 2002
Airway inflammation in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 14-31
Year: 2014
Mechanisms and markers of airway inflammation in cystic fibrosis
Source: Eur Respir J 2002; 19: 333-340
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept